TABLE 2.
Clones, their phenotypes, and the corresponding enzymes obtained from amino acid substitution in the CTX-M-9 enzyme during three cycles of mutagenesis
| Cycle of mutagenesis | Clone | Resistance phenotype | Enzyme | Substitution(s) |
|---|---|---|---|---|
| First (round A) | A1 | 1a | M-A1 | D240G |
| A2 | 1 | M-A2 | D240G, V29A | |
| A3 | 1 | M-A3 | D240G, I173T | |
| A4 | 2b | M-A4 | L169Q | |
| A5 | 2 | M-A5 | P167S, N106S | |
| A6 | 2 | M-A6 | P167S | |
| A7 | 2 | M-A7 | D179G, N106S, T86A | |
| A8 | 2 | M-A8 | R276S, A231V, R164H | |
| Second (round B) | A1B1 | 1 | M-A1B1 | D240G, R276H, Q87L |
| A1B2 | 1 | M-A1B1 | D240G, A219D | |
| A4B1 | 2 | M-A4B1 | D240G, L169Q | |
| A5B1 | 2 | M-A5B1 | P167S, N106S, T159S | |
| A6B1 | 2 | M-A6B1 | P167S, A109T | |
| A7B1 | 2 | M-A7B1 | D179G, N106S, T86A, A231V, T165I | |
| A7B2 | 2 | M-A7B2 | D179G, N106S, T86A, A231V | |
| A7B3 | 2 | M-A7B3 | D179G, N106S, T86A, R276H | |
| A8B1 | 2 | M-A8B1 | R276S, A231V, R164H, P167S | |
| A8B2 | 2 | M-A8B2 | R276S, A231V, R164H, P167H | |
| A8B3 | 2 | M-A8B3 | R276S, A231V, R164H, G289E, Q188R, D179N | |
| A8B4 | 2 | M-A8B4 | R2768, A231V, R164H, D179Y | |
| Third (round C) | A1B1C1 | 1 | M-A1B1C1 | D240G, R276H, Q87L, H112Y, T230I, A231V |
| A1B2C1 | 2 | M-A1B2C1 | D240G, A219D, G289W, H197R, L169M | |
| A5B1C1 | 2 | M-A5B1C1 | P167S, N106S, T159S, T171S, T209S | |
| A5B1C2 | 2 | M-A5B1C2 | P167S, N106S, T159S, A140V, A231V | |
| A6B1C1 | 2 | M-A6B1C1 | P167S, A109T, G146R, T227A, Q254P | |
| A6B1C2 | 2 | M-A6B1C2 | P167S, A109T, E166V | |
| A6B1C3 | 2 | M-A6B1C3 | P167S, A109T, E201D | |
| A6B1C4 | 2 | M-A6B1C4 | P167S, A109T, A231V | |
| A6B1C5 | 2 | M-A6B1C5 | P167S, A109T, A172V | |
| A6B1C6 | 2 | M-A6B1C6 | P167S, A109T, A77V, P268A |
Resistance phenotype 1 exhibits similar MICs for cefotaxime and ceftazidime.
Resistance phenotype 2 exhibits higher MICs for ceftazidime than for cefotaxime.